SlideShare une entreprise Scribd logo
1  sur  45
Télécharger pour lire hors ligne
Wolters Kluwer
2015 Full-Year Results
Nancy McKinstry – CEO
Kevin Entricken – CFO
February 24, 2016
2015 Full-Year Results 2
This presentation contains forward-looking statements. These statements may be identified by
words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer
cautions that such forward-looking statements are qualified by certain risks and uncertainties
that could cause actual results and events to differ materially from what is contemplated by the
forward-looking statements. Factors which could cause actual results to differ from these
forward-looking statements may include, without limitation, general economic conditions,
conditions in the markets in which Wolters Kluwer is engaged, behavior of customers, suppliers
and competitors, technological developments, the implementation and execution of new ICT
systems or outsourcing, legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as
well as risks related to mergers, acquisitions and divestments. In addition, financial risks, such as
currency movements, interest rate fluctuations, liquidity and credit risks could influence future
results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer
disclaims any intention or obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
Growth rates are cited in constant currencies unless otherwise noted.
Forward-looking Statements
2015 Full-Year Results 3
 Introduction
 Financial Review
 Strategic and Operating Review
 Outlook 2016
 Appendix
Agenda
2015 Full-Year Results 4
 Organic growth improved to +3%
– Digital & services revenues grew +5% organically (83% of total revenues)
 Met or exceeded guidance
– Adjusted operating profit margin increased in line with guidance
– Adjusted free cash flow up +7% in constant currencies, better than expected
– ROIC improved
– Diluted adjusted EPS up +5% in constant currencies, in line with guidance
 Outlook 2016
– Increasing returns to shareholders (dividend and share buyback)
– Our plan for 2016-2018 builds on the strategic direction we have been following
– Guidance 2016: mid-single-digit growth in diluted adjusted EPS in constant currencies,
supported by organic growth and margin improvement
Introduction
Strategy is delivering improved performance
2015 Full-Year Results 5
Strategic progress
Key achievements 2015
▪ Delivered 7% organic growth in leading, growth positions
▪ Acquired Learner’s Digest International in Health and
smaller bolt-on assets in Tax & Accounting
▪ Divested Russia and several non-core assets
▪ Sustained investment in new and enhanced products at
8-10% of revenues
▪ Launched UpToDate China, Cheetah, and several other
innovations across all divisions
▪ Formed new division: Governance, Risk & Compliance
▪ Executed on operational excellence programs
▪ Merged medical research and books businesses
▪ Leveraged technology platforms and components across
borders
Expand
our leading,
high growth
positions
Deliver
solutions and
insights
Drive
efficiencies
2015 Full-Year Results 6
 Introduction
 Financial Review
 Strategic and Operating Review
 Outlook 2016
 Appendix
Agenda
2015 Full-Year Results 7
Full-year 2015 results
Organic growth accelerated, operating margin and ROIC improved
(€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Revenues 4,208 3,660 +15% +3% +3%
Adjusted operating profit 902 768 +17% +2% +3%
Adjusted operating profit margin 21.4% 21.0%
Diluted adjusted EPS €1.96 €1.57 +25% +5%
Adjusted free cash flow 647 516 +26% +7%
Net-debt-to-EBITDA ratio 1.7x 2.1x
Return on Invested Capital 9.3% 8.5%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
2015 Full-Year Results 8
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Health 1,022 816 +25% +6% +5%
Tax & Accounting 1,132 989 +14% +4% +3%
Governance, Risk & Compliance 1,065 854 +25% +7% +5%
Legal & Regulatory 989 1,001 -1% -5% -2%
Total revenues 4,208 3,660 +15% +3% +3%
FY 2015 Revenues
Revenues – new divisions
Organic growth in Health, Tax & Accounting, and Governance, Risk & Compliance
more than offset decline in Legal & Regulatory
Health
24%
Tax &
Accounting
27%
Governance
Risk &
Compliance
25%
Legal &
Regulatory
24%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
2015 Full-Year Results 9
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Legal & Regulatory 1,626 1,497 +9% 0% 0%
Tax & Accounting 1,078 946 +14% +3% +3%
Health 1,022 816 +25% +6% +5%
Financial & Compliance Services 482 401 +20% +6% +6%
Total revenues 4,208 3,660 +15% +3% +3%
FY 2015 Revenues
Revenues – previous divisions
Tax & Accounting, Health and Financial & Compliance Services drive growth
Legal &
Regulatory
39%
Tax &
Accounting
26%
Health
24%
F&CS
11%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
2015 Full-Year Results 10
Revenues by region
Organic growth continues to be driven by North America and Asia Pacific & ROW
North
America
59%
Europe
33%
AsiaPac
& ROW
8%
FY 2015 Revenues
∆ OG:
+5% (+3%)
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
North America 2,509 1,999 +26% +5% +5%
Europe 1,371 1,373 0% -1% -1%
AsiaPac & ROW 328 288 +14% +4% +4%
Total revenues 4,208 3,660 +15% +3% +3%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
Legend:
∆ OG - % Organic Growth FY 2015 (FY 2014)
∆ OG:
-1% (0%)
∆ OG:
+4% (+7%)
2015 Full-Year Results 11
Digital
70%
Services
13%
Print
17%
Revenues by media format
Digital revenues sustained 6% organic growth
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Digital 2,962 2,472 +20% +7% +6%
Services 523 453 +16% 0% +3%
Print 723 735 -1% -9% -7%
Total revenues 4,208 3,660 +15% +3% +3%
FY 2015 Revenues
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
∆ OG:
+6% (+6%)
∆ OG:
-7% (-9%)
∆ OG:
+3% (0%)
Legend:
∆ OG - % Organic Growth FY 2015 (FY 2014)
2015 Full-Year Results 12
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Margin
FY 2015
Margin
FY 2014
Health 247 197 +25% +5% +4% 24.1% 24.1%
Tax & Accounting 311 261 +19% +7% +8% 27.5% 26.4%
Governance, Risk & Compliance 298 232 +29% +9% +8% 28.0% 27.1%
Legal & Regulatory 96 127 -24% -28% -23% 9.7% 12.7%
Corporate (50) (49) +4% 0% 0%
Adjusted operating profit 902 768 +17% +2% +3% 21.4% 21.0%
FY 2015 Adjusted Operating Profit
Adjusted operating profit – new divisions
Margin increases in Tax & Accounting and Governance, Risk & Compliance more
than offset expected decline in Legal & Regulatory margin
Legal &
Regulatory
10%
Tax &
Accounting
33%
Health
26%
Governance
Risk &
Compliance
31%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
* Excluding corporate
2015 Full-Year Results 13
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Margin
FY 2015
Margin
FY 2014
Legal & Regulatory 320 305 +5% -8% -7% 19.7% 20.3%
Tax & Accounting 295 250 +18% +6% +7% 27.4% 26.4%
Health 247 197 +25% +5% +4% 24.1% 24.1%
Financial & Compliance Services 90 65 +37% +21% +21% 18.6% 16.3%
Corporate (50) (49) +4% 0% 0%
Adjusted operating profit 902 768 +17% +2% +3% 21.4% 21.0%
FY 2015 Adjusted Operating Profit
Adjusted operating profit – previous divisions
Financial & Compliance Services was a key contributor to the margin increase
Legal &
Regulatory
34%
Tax &
Accounting
31%
Health
26%
F&CS
9%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
* Excluding corporate
2015 Full-Year Results 14
Adjusted net profit and EPS
Diluted adjusted EPS up +5% in constant currencies
(€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC
Revenues 4,208 3,660 +15% +3%
Adjusted operating profit 902 768 +17% +2%
Adjusted operating profit margin 21.4% 21.0%
Adjusted net financing costs (119) (113)
Equity-accounted investees, net of tax 0 (1)
Adjusted profit before tax 783 654 +20% +3%
Tax on adjusted profit (199) (182)
Effective benchmark tax rate 25.5% 27.6%
Non-controlling interests (1) (2)
Adjusted net profit 583 470 +24% +4%
Diluted weighted average shares (million) 297.4 299.9
Diluted adjusted EPS €1.96 €1.57 +25% +5%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33).
2015 Full-Year Results 15
IFRS profit and diluted EPS
Reported EPS declines 10%, reflecting one-off factors related to tax
(€ million, unless otherwise stated) FY 2015 FY 2014 ∆
Adjusted operating profit 902 768 +17%
Amortization of acquired intangibles (214) (192)
Results on divestments of operations (14) 10
Acquisition integration costs and other non-benchmark items (7) (17)
Operating profit 667 569 +17%
Financing results1) (125) (56)
Share of profit of equity-accounted investees, net of tax 0 (1)
Profit before tax 542 512 +6%
Income tax expense (119) (38)
Effective tax rate2) 21.9% 7.4%
Profit for the period 423 474 -11%
Non-controlling interests 0 (1)
Profit for the period to the owners of the Company 423 473 -11%
Diluted EPS €1.42 €1.58 -10%
∆: % Change
1) Includes the financing component of employee benefits (€5 million in 2015 and 2014). In 2014, includes €76 million revaluation gain on Datacert.
2) 2014 effective tax rate reflects the non-taxable revaluation gain on Datacert, a positive tax impact relating to previously divested assets, and a tax charge on internal asset transfers.
2015 Full-Year Results 16
Adjusted free cash flow
Cash conversion of 100%, better than expected
(€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC
Adjusted operating profit 902 768 +17% +2%
Depreciation and amortization of other intangibles 171 140
Adjusted EBITDA 1,073 908 +18% +3%
Capital expenditure (188) (148)
Autonomous movements in working capital 18 4
Adjusted operating cash flow 903 764 +18% +4%
Cash conversion ratio 100% 100%
Paid financing costs (101) (135)
Paid corporate income tax1) (141) (101)
Net change in restructuring provision2) (6) (9)
Other3) (8) (3)
Adjusted free cash flow 647 516 +26% +7%
Springboard, net of tax2) - (4)
Adjusted free cash flow, incl. Springboard4) 647 512 +26% +7%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33).
1) 2014 adjusted for tax on appropriation of Springboard provisions.
2) In 2015, the appropriation of Springboard provisions (€3 million) was included in adjusted free cash flow. In 2014, the appropriation of Springboard provisions was treated as a
non-benchmark item.
3) ‘Other’ includes share-based payments, dividends received, an adjustment to remove a €22 million income tax benefit relating to previously divested assets (2014: €18 million)
and a €5 million transactional tax payment relating to the 2014 internal asset transfers.
4) Adjusted free cash flow excludes additions to provisions for acquisition integration.
2015 Full-Year Results 17
Movement in net debt
Leverage ratio improved to 1.7x, despite over 55% of free cash flow returned to
shareholders
(€ million, unless otherwise stated) FY 2015 FY 2014
Net debt at January 1 (1,897) (1,988)
Adjusted free cash flow, incl. Springboard 647 512
Dividends paid (263) (209)
Acquisition spending, net of cash acquired, including costs (183) (189)
Divestiture cash proceeds, including costs, net of cash disposed 22 27
Share repurchases (140) (25)
Other1) 26 (25)
Movement in net debt 109 91
Net debt at December 31 (1,788) (1,897)
Net-debt-to-EBITDA ratio 1.7x 2.1x
1) In 2015, ‘Other’ includes a €22 million income tax benefit on previously divested assets, a €5 million one-off tax payment on internal asset transfers, as well as adjustments for
FX differences in cash and cash equivalents, changes in the fair value of derivatives, and other items.
2015 Full-Year Results 18
Leverage
Net-debt-to-EBITDA improved to 1.7x, better than target level
2.7x
3.1x
2.4x
2.2x 2.1x
1.7x
2010 2011 2012 2013 2014 2015
Net-Debt-to-EBITDA (Ratio)
Target:
2.5x
2015 Full-Year Results 19
Dividend
Proposing full-year total dividend of €0.75 per share, up +6%
Dividend per Share (€)1)
1) Dividend declared for the year indicated
 2015: introduced semi-annual dividend
frequency. Interim dividend of €0.18
paid in October 2015
 Proposing final dividend of €0.57,
subject to AGM approval, to be paid in
May 2016
 2015: 10th consecutive year of increase
in dividend per share
 Progressive dividend policy: committed
to increase the total dividend per share
each year
Proposed
final
dividend
€0.57
0.55
0.58
0.64 0.65 0.66 0.67 0.68 0.69 0.70 0.71
0.75
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Interim
dividend
€0.18
2015 Full-Year Results 20
Share buybacks
Completed €140 million share buyback in 2015. Announcing up to €600 million
buyback over the next three years (2016-2018)
 Committed to anti-dilution policy to
offset dilution caused by
performance share issuance
 Announcing intention to buy back up
to €600 million in shares over three
years (2016-2018), including anti-
dilution buybacks
 Ample headroom to continue
investing in the business, including
acquisitions
100
135
20 25
140
2011 2012 2013 2014 2015 2016 2017 2018
Share Buybacks (€ million)
Share Buyback
Program
2016-2018:
up to
€600 million
2015 Full-Year Results 21
 Organic growth accelerated to +3%
 Adjusted operating margin 21.4%, increased by 40 basis points
 Diluted adjusted EPS €1.96, up +5% in constant currencies
 Adjusted free cash flow of €647 million, up +7% in constant currencies
 Net-debt-to-EBITDA ratio improved to 1.7x
 Proposing full-year total dividend of €0.75 per share
 Announcing up to €600 million share buyback over three years (2016-2018),
including anti-dilution buybacks
Summary
2015 Full-Year Results 22
 Introduction
 Financial Review
 Strategic and Operating Review
 Outlook 2016
 Appendix
Agenda
2015 Full-Year Results 23
Health
Sustained +5% organic growth; margin reflects increased investment and
restructuring
Clinical
Solutions
47%
Health
Learning,
Research &
Practice
53%
North
America
73%
Europe
10%
AsiaPac
& ROW
17%
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 1,022 816 +25% +6% +5%
Adjusted
operating profit
247 197 +25% +5% +4%
Margin 24.1% 24.1%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
Clinical Solutions
 Organic growth +10%, driven by double-
digit growth of UpToDate
 Drug information sustained robust growth
 Medical documentation and informatics
were subdued, facing tough comparable
and longer sales lead times
 Increased investment in sales and
marketing and product development
Health Learning, Research & Practice
 Organic growth improved to +1%
 Digital growth outweighed print decline
 Increased restructuring to merge former
journal and book units
 Acquisition of digital leader in continuing
medical education, Learner’s Digest Int’l
Revenues by Geographic MarketRevenues by Segments
2015 Full-Year Results 24
Tax &
Accounting
software
71%
Other
digital
16%
Services
6%
Print
7%
Tax & Accounting
Organic growth +3% supported by software +6%; margins improved
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 1,132 989 +14% +4% +3%
Adjusted
operating profit
311 261 +19% +7% +8%
Margin 27.5% 26.4%
North
America
59%
Europe
30%
AsiaPac &
ROW
11%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
Revenues by Media Format Revenues by Geographic Market
North America
 Good organic growth driven by software
and other digital products
 Cloud-based suite, CCH Axcess, continues
to migrate and attract new users
 Print, bank products, and training remain
weak
Europe
 Good organic growth in most countries
 On-premise software performed well
 Investing in cloud-based and collaborative
solutions
Asia Pacific & ROW
 Growth abates to low single-digit rate
 Software growth partly offset by print
Audit (TeamMate)
 Double-digit organic growth driven by
new software sales
2015 Full-Year Results 25
North
America
84%
Europe
13%
AsiaPac &
ROW
3%
Governance, Risk & Compliance
Organic growth +5%, buoyed by non-recurring revenues; margins improved
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 1,065 854 +25% +7% +5%
Adjusted
operating profit
298 232 +29% +9% +8%
Margin 28.0% 27.1%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
Corporate
Legal
Services
60%
Finance,
Risk &
Complianc
21%
Transport
Svcs
4%
Originations
15%
Corporate Legal Services
 Organic growth +6%, including +2% in 4Q
 CLS transactional revenues +8%
 All areas performed well
Originations
 High single-digit organic growth driven by
TILA-RESPA regulation
 FS transactional declined against tough
comparable
Finance, Risk & Compliance
 Organic growth +6%, despite challenging
comparable
 Higher non-recurring license and
implementation fees
 Steady growth in recurring revenues
Transport Services (Europe)
 Revenues decline moderated; margins
improved
Revenues by Segments Revenues by Geographic Market
2015 Full-Year Results 26
Digital
48%
Services
11%
Print
41%
North
America
20%
Europe
79%
AsiaPac &
ROW
1%
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 989 1,001 -1% -5% -2%
Adjusted
operating profit
96 127 -24% -28% -23%
Margin 9.7% 12.7%
Legal & Regulatory
Organic decline as print still outweighs digital growth; margins impacted by
planned increase in restructuring
Revenues by Media Format
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
Legal & Regulatory
 Organic growth -2%, improving modestly
(2014: -3%)
 Digital revenues up +1% organically
 Investing in legal and regulatory
compliance software
 Acquisition of Effacts, legal management
software for corporate counsel, supports
strategy
 Print formats continued to decline,
although books improved due to
publishing schedules and front list
 Margin contracted, as expected, due to
increased costs, including restructuring
 Divested Russia (55% interest) and non-
core assets in the U.K., U.S. and Germany
Revenues by Geographic Market
2015 Full-Year Results 27
61%
70%
13%
13%
26%
17%
2012 2015
Digital
Services
Print
74% 76%
17% 17%
9% 7%
2012 2015
Recurring
Non-recurring
Print Books
Revenues by Media Format
Strategy 2013-2015
Our strategy of the past few years has driven continued portfolio transformation
Note: 2012 excludes discontinued operations. Revenue breakdown by media format and type reflects updated product classifications introduced in 2014.
54% 59%
6%
8%
40%
33%
2012 2015
Europe
Asia Pacific & RoW
North America
Revenues by Type Revenues by Geographic Market
& transactional
2015 Full-Year Results 28
Strategy 2013-2015
Leading, high growth units, now 51% of total revenues, grew +7% organically
39%
71%
47%
58%
+6%
+7%
+10%
+5%
1) Previous divisional structure.
% of
divisional
revenues
2015
Organic Growth
Leading High Growth Units
2015
28%
56%
38%
49%
2012
Corporate Legal
Services
Finance, Risk &
Compliance; Audit
Clinical
Solutions
Tax & Accounting
Software
40% of total revenues 51% of total revenues
Legal &
Regulatory
F&CS
Health
Tax &
Accounting
Divisions:1)
Total
Leading
High
Growth
+7%
2015 Full-Year Results 29
Organic growth and margin
Organic growth accelerated and margin improved
-3%
0%
1% 1% 1%
2%
3%
2%
4% 4%
5% 5%
6% 6%
2009 2010 2011 2012 2013 2014 2015
Note: Organic growth and Adjusted operating profit margin as reported. 2011-2013 reflects continuing operations. All restructuring costs included in adjusted operating profit margin
since 2012. 2012 restated for IAS 19R (Employee benefits) and early adoption of IFRS 11 (Joint arrangements). Digital revenue growth as of 2014 reflects updated product classifications.
Digital revenues
Total Wolters Kluwer
Organic Growth (%)
19.9%
20.4%
21.7% 21.5% 21.5%
21.0%
21.4%
2009 2010 2011 2012 2013 2014 2015
Adjusted Operating Profit Margin (%)
2015 Full-Year Results 30
Continued
pressure on
professionals to
improve
outcomes and
productivity
Increasing
volume and
complexity of
global
regulation, risk
and compliance
High growth of
professionals in
developing
economies
Increasing
disruption from
cloud, mobile,
social media, Big
Data & Artificial
Intelligence
5
Market trends
Changing customer needs are creating opportunities and challenges
Changing
client needs:
millennials work
differently and
seek rich digital
experience
421 3
2015 Full-Year Results 31
Strategic priorities 2016-2018
Our plan for 2016-2018 builds on the strategic direction of the past three years
▪ Allocate majority of capital to leading, growing businesses
▪ Extend into adjacent market segments and new geographies
▪ Broaden our global sales and marketing coverage
▪ Deliver expert solutions providing improved outcomes and productivity
▪ Accelerate development of global platforms and cloud-based solutions
▪ Expand new media marketing channels
▪ Continue investing 8-10% of revenues into new and enhanced products
▪ Continue driving scale economies while improving quality and agility
▪ Leverage our technology investments through increased standardization
of processes and technology planning
▪ Foster employee engagement
Expand
Market Coverage
Deliver
Expert Solutions
Drive
Efficiencies &
Engagement
2015 Full-Year Results 32
Product innovation
Continued investment in Expert Solutions and other digital innovation
Cheetah
New intuitive legal research platform
UpToDate
Clinical decision support resource for
healthcare practitioners
2015
 Double-digit organic growth; reached 1.1 million
users globally
 Unveiled 23rd specialty - Sports Medicine
 Commercial launch in China
– 4,800 topics translated by year-end 2015
– Signed first customers
2015
 Greatly enhanced usability, speed and accuracy of
research results
 Offers Federal, State, and International Tax Law;
Intellectual Property Law to be released in 1H 2016
 Upgrading existing users and attracting new
customers
2015 Full-Year Results 33
 Introduction
 Financial Review
 Strategic and Operating Review
 Outlook 2016
 Appendix
Agenda
2015 Full-Year Results 34
Divisional outlook 2016
Legal & Regulatory
 Expect positive but slower organic growth, due to challenging comparables for
transactional and non-recurring revenues, particularly in the first half
 Margins expected to improve slightly
Tax & Accounting
 Expect underlying revenue growth to improve slightly, driven by continued mix
shift towards software solutions
 Margin expected to ease in the first half, but to be maintained for the full year
Health
 Another year of good organic growth, supported by robust growth in Clinical
Solutions and gradually improving trend in Health Learning, Research & Practice
 Expect slight margin improvement as we continue to invest to drive growth
Governance, Risk &
Compliance
 Expect organic revenue decline similar to 2015, with print trends continuing to
outweigh digital growth. First half growth to benefit from timing and one-offs
 Margin expected to improve due to lower restructuring costs. Efficiency savings
are expected to fund wage inflation and increased investment
2015 Full-Year Results 35
Guidance 2016
Performance indicators FY 2016 Guidance
Adjusted operating profit margin 21.5%–22.0%
Adjusted free cash flow €600-€625 million
Return on invested capital > 9%
Diluted adjusted EPS Mid-single-digit growth
Guidance for adjusted free cash flow and diluted adjusted EPS is in constant currencies (EUR/USD 1.11). Guidance for EPS growth assumes the announced share
repurchases are equally spread over 2016-2018. Adjusted operating profit margin and ROIC are in reported currency.
Additional information:
Expect adjusted net financing costs of approximately €105 million, excluding the impact of
exchange rate movements.
Expect the benchmark effective tax rate to return to the range of 27% - 28%.
Expect a cash conversion ratio of approximately 95%, with capital expenditure rising to around
5% of total revenue.
Q&A
Appendix
2015 Full-Year Results 38
(€ million, unless otherwise stated) Dec. 31, 2015 Dec. 31, 2014
Goodwill and intangible assets 5,550 5,172
Equity-accounted investees and financial assets 30 32
Other non-current assets 208 216
Non-current assets 5,788 5,420
Cash and cash equivalents 812 535
Other current assets 1,499 1,381
Deferred income (1,522) (1,344)
Short-term borrowings and bank overdrafts (286) (125)
Other current liabilities (962) (924)
Working capital (459) (477)
Capital employed 5,329 4,943
Total equity 2,477 2,121
Long-term debt 2,306 2,304
Other non-current liabilities 546 518
Total financing 5,329 4,943
Closing rate EUR/USD 1.09 1.21
Balance Sheet
2015 Full-Year Results 39
Reconciliation: Adjusted net financing
costs to financing results
(€ million) FY 2015 FY 2014
Adjusted net financing costs (119) (113)
Loss on investment available-for-sale - (14)
Employee benefits financing component (5) (5)
Divestment related results on equity-accounted investees (1) 76
Financing results (125) (56)
2015 Full-Year Results 40
Recurring
76%
Print books
7%
Other non-
recurring
17%
Revenues by type
(€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG
Digital and services subscriptions 2,561 2,155 +19% +6% +5%
Print subscriptions 314 341 -8% -12% -9%
Other recurring 326 281 +16% +1% +0%
Recurring revenues 3,201 2,777 +15% +3% +3%
Print books 299 289 +4% -6% -5%
CLS transactional 278 215 +29% +8% +8%
FS transactional 42 37 +14% -5% -5%
Other non-recurring 388 342 +13% +3% +3%
Total revenues 4,208 3,660 +15% +3% +3%
FY 2015 Revenues
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
2015 Full-Year Results 41
Recurring
82%
Print books
12%
Other non-
recurring
6%
Digital
78%
Services
1%
Print
21%
Revenues by media format and type
Tax &
Accounting
software
71%
Digital:
other
16%
Services
6%
Print
7%
Tax & Accounting
Recurring
89%
Print books
3%
Other non-
recurring
8%
Health
Governance, Risk &
Compliance
Legal & Regulatory
Digital
66%
Services
32%
Print
2%
Recurring
59%
CLS
transactional
26%
FS
transactional
4% Other non-
recurring
11%
Digital
48%
Services
11%
Print
41%
Recurring
74%
Print books
14%
Other non-
recurring
12%
FY 2015 Revenues
2015 Full-Year Results 42
Debt maturity profile
294
752
12
248
5
697
196
396
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 >2025
Debt Maturity Profile (€ million)
year-end
Cash & cash
equivalents
812
Debt due in 2016 includes €285 million of bank overdrafts used for cash management purposes.
Total cash and cash equivalents, less bank overdrafts used for cash management purposes, were €527 million.
2015 Full-Year Results 43
Tax &
Accounting
software
71%
Digital:
other
16%
Services
6%
Print
7%
Former Tax & Accounting
North
America
60%
Europe
31%
AsiaPac
& ROW
9%
Revenues by Media Format Revenues by Geographic Market
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 1,078 946 +14% +3% +3%
Adjusted
operating profit
295 250 +18% +6% +7%
Margin 27.4% 26.4%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth
2015 Full-Year Results 44
Former Financial & Compliance Services
Originations
34%
Finance,
Risk &
Compliance
47%
Audit
11%
Transport
Svcs
8%
North
America
65%
Europe
26%
AsiaPac
& ROW
9%
F&CS Segments
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 482 401 +20% +6% +6%
Adjusted
operating profit
90 65 +37% +21% +21%
Margin 18.6% 16.3%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth
Revenues by Geographic Market
2015 Full-Year Results 45
Corporate
Legal
Services
39%
Legal &
Regulatory
Solutions
61%
North
America
50%
Europe
50%
L&R Segments
€ million FY 2015 FY 2014 Δ Δ CC Δ OG
Revenues 1,626 1,497 +9% 0% 0%
Adjusted
operating profit
320 305 +5% -8% -7%
Margin 19.7% 20.3%
∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth
Former Legal & Regulatory
Revenues by Geographic Market

Contenu connexe

Tendances

Wolters Kluwer 2005 Half-Year Results
Wolters Kluwer 2005 Half-Year ResultsWolters Kluwer 2005 Half-Year Results
Wolters Kluwer 2005 Half-Year Results
Wolters Kluwer
 
AkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor PresentationAkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor Presentation
AkzoNobel
 
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
vefinance
 
1H 2015 Consolidated Results
1H 2015 Consolidated Results 1H 2015 Consolidated Results
1H 2015 Consolidated Results
Terna SpA
 

Tendances (19)

AkzoNobel Investor Update Q1 2014 results
AkzoNobel Investor Update Q1 2014 resultsAkzoNobel Investor Update Q1 2014 results
AkzoNobel Investor Update Q1 2014 results
 
AkzoNobel Q3 2013 Investor Presentation
AkzoNobel Q3 2013 Investor PresentationAkzoNobel Q3 2013 Investor Presentation
AkzoNobel Q3 2013 Investor Presentation
 
4Q12 Results Presentation
4Q12 Results Presentation4Q12 Results Presentation
4Q12 Results Presentation
 
4Q11 Results Presentation
4Q11 Results Presentation4Q11 Results Presentation
4Q11 Results Presentation
 
Klöckner & Co - Q1 2012 Results
Klöckner & Co - Q1 2012 ResultsKlöckner & Co - Q1 2012 Results
Klöckner & Co - Q1 2012 Results
 
Wolters Kluwer 2005 Half-Year Results
Wolters Kluwer 2005 Half-Year ResultsWolters Kluwer 2005 Half-Year Results
Wolters Kluwer 2005 Half-Year Results
 
AkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor PresentationAkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor Presentation
 
Generali Group 2015 First Half Results
Generali Group 2015 First Half ResultsGenerali Group 2015 First Half Results
Generali Group 2015 First Half Results
 
SGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance MeasuresSGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance Measures
 
Generali Group 9M Results 2015
Generali Group 9M Results 2015Generali Group 9M Results 2015
Generali Group 9M Results 2015
 
Snam 2015 3Q results
Snam 2015 3Q resultsSnam 2015 3Q results
Snam 2015 3Q results
 
Q4 15 slides ugi-final
Q4 15 slides ugi-finalQ4 15 slides ugi-final
Q4 15 slides ugi-final
 
AkzoNobel Investor Update Q3 2014 results
AkzoNobel Investor Update Q3 2014 resultsAkzoNobel Investor Update Q3 2014 results
AkzoNobel Investor Update Q3 2014 results
 
AkzoNobel Q3 2014 Media presentation
AkzoNobel Q3 2014 Media presentationAkzoNobel Q3 2014 Media presentation
AkzoNobel Q3 2014 Media presentation
 
Generali Group 1Q 2015 Results
Generali Group 1Q 2015 ResultsGenerali Group 1Q 2015 Results
Generali Group 1Q 2015 Results
 
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
Chiffres clés au 31 mars 2015 - Conférence téléphonique du 7 mai 2015 (en ang...
 
Suominen Corporation results presentation Q1 2016
Suominen Corporation results presentation Q1 2016Suominen Corporation results presentation Q1 2016
Suominen Corporation results presentation Q1 2016
 
Generali Group Results at 31 December 2015
Generali Group Results at 31 December 2015Generali Group Results at 31 December 2015
Generali Group Results at 31 December 2015
 
1H 2015 Consolidated Results
1H 2015 Consolidated Results 1H 2015 Consolidated Results
1H 2015 Consolidated Results
 

Similaire à 2015 Full-Year Results

Markit q1'15 results presentation
Markit q1'15 results presentationMarkit q1'15 results presentation
Markit q1'15 results presentation
InvestorMarkit
 
Q4 14 results presentation final
Q4 14 results presentation  finalQ4 14 results presentation  final
Q4 14 results presentation final
InvestorMarkit
 
Mrkt q3 14 results presentation
Mrkt q3 14 results presentationMrkt q3 14 results presentation
Mrkt q3 14 results presentation
InvestorMarkit
 
Textura q1 15 earnings release presentation v4
Textura q1 15 earnings release presentation v4Textura q1 15 earnings release presentation v4
Textura q1 15 earnings release presentation v4
TexturaCorp
 
27 august-2015-fy15-annual-results-presentation
27 august-2015-fy15-annual-results-presentation27 august-2015-fy15-annual-results-presentation
27 august-2015-fy15-annual-results-presentation
absmartkarma
 

Similaire à 2015 Full-Year Results (20)

2013 Full Year Results
2013 Full Year Results2013 Full Year Results
2013 Full Year Results
 
Q1 2015 RESULTS by sanofi
Q1 2015 RESULTS by sanofiQ1 2015 RESULTS by sanofi
Q1 2015 RESULTS by sanofi
 
Textura q2 15 earnings release presentation
Textura q2 15 earnings release presentationTextura q2 15 earnings release presentation
Textura q2 15 earnings release presentation
 
Markit q1'15 results presentation
Markit q1'15 results presentationMarkit q1'15 results presentation
Markit q1'15 results presentation
 
Close brothers prelim_2015
Close brothers prelim_2015Close brothers prelim_2015
Close brothers prelim_2015
 
Q4 14 results presentation final
Q4 14 results presentation  finalQ4 14 results presentation  final
Q4 14 results presentation final
 
Q4 15 earnings slides final
Q4 15 earnings slides finalQ4 15 earnings slides final
Q4 15 earnings slides final
 
2015 results and outlook 2016 2020
2015 results and outlook 2016 20202015 results and outlook 2016 2020
2015 results and outlook 2016 2020
 
Mrkt q3 14 results presentation
Mrkt q3 14 results presentationMrkt q3 14 results presentation
Mrkt q3 14 results presentation
 
Ofx 260515 fy15_presentation
Ofx 260515 fy15_presentationOfx 260515 fy15_presentation
Ofx 260515 fy15_presentation
 
Q4 15 results presentation final
Q4 15 results presentation finalQ4 15 results presentation final
Q4 15 results presentation final
 
Textura q1 15 earnings release presentation v4
Textura q1 15 earnings release presentation v4Textura q1 15 earnings release presentation v4
Textura q1 15 earnings release presentation v4
 
Textura q3 15 earnings release presentation
Textura q3 15 earnings release presentationTextura q3 15 earnings release presentation
Textura q3 15 earnings release presentation
 
27 august-2015-fy15-annual-results-presentation
27 august-2015-fy15-annual-results-presentation27 august-2015-fy15-annual-results-presentation
27 august-2015-fy15-annual-results-presentation
 
Solvay 9 months 2018 results - Presentation
Solvay 9 months 2018 results - PresentationSolvay 9 months 2018 results - Presentation
Solvay 9 months 2018 results - Presentation
 
HeidelbergCement: Q3 2014 Presentation
HeidelbergCement: Q3 2014 PresentationHeidelbergCement: Q3 2014 Presentation
HeidelbergCement: Q3 2014 Presentation
 
HeidelbergCement: Q1 2015 Presentation
HeidelbergCement: Q1 2015 PresentationHeidelbergCement: Q1 2015 Presentation
HeidelbergCement: Q1 2015 Presentation
 
Guidance presentation jan 2015 final2
Guidance presentation jan 2015 final2Guidance presentation jan 2015 final2
Guidance presentation jan 2015 final2
 
Trc q1 2016 earnings slides final
Trc q1 2016 earnings slides finalTrc q1 2016 earnings slides final
Trc q1 2016 earnings slides final
 
Q2 2016 earnings call presentation final v2
Q2 2016 earnings call presentation final v2Q2 2016 earnings call presentation final v2
Q2 2016 earnings call presentation final v2
 

Plus de Wolters Kluwer

2012 Full-Year Results presentation
2012 Full-Year Results presentation2012 Full-Year Results presentation
2012 Full-Year Results presentation
Wolters Kluwer
 
2012 Investor Event: Wolters Kluwer Financial & Compliance Services
2012 Investor Event: Wolters Kluwer Financial & Compliance Services2012 Investor Event: Wolters Kluwer Financial & Compliance Services
2012 Investor Event: Wolters Kluwer Financial & Compliance Services
Wolters Kluwer
 
GAPP Visit to Wolters Kluwer Headquarters
GAPP Visit to Wolters Kluwer HeadquartersGAPP Visit to Wolters Kluwer Headquarters
GAPP Visit to Wolters Kluwer Headquarters
Wolters Kluwer
 
Wolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year ResultsWolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year Results
Wolters Kluwer
 
Wolters Kluwer 2006 Full-Year Results
Wolters Kluwer 2006 Full-Year ResultsWolters Kluwer 2006 Full-Year Results
Wolters Kluwer 2006 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2010 Full-Year Results
Wolters Kluwer 2010 Full-Year ResultsWolters Kluwer 2010 Full-Year Results
Wolters Kluwer 2010 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2010 Half-Year Results
Wolters Kluwer 2010 Half-Year ResultsWolters Kluwer 2010 Half-Year Results
Wolters Kluwer 2010 Half-Year Results
Wolters Kluwer
 
Wolters Kluwer 2009 Full-Year Results
Wolters Kluwer 2009 Full-Year ResultsWolters Kluwer 2009 Full-Year Results
Wolters Kluwer 2009 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2009 Half-Year Results
Wolters Kluwer 2009 Half-Year ResultsWolters Kluwer 2009 Half-Year Results
Wolters Kluwer 2009 Half-Year Results
Wolters Kluwer
 
Wolters Kluwer 2008 Full-Year Results
Wolters Kluwer 2008 Full-Year ResultsWolters Kluwer 2008 Full-Year Results
Wolters Kluwer 2008 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2008 Half-Year Results
Wolters Kluwer 2008 Half-Year ResultsWolters Kluwer 2008 Half-Year Results
Wolters Kluwer 2008 Half-Year Results
Wolters Kluwer
 
Wolters Kluwer 2006 Half-Year Results
Wolters Kluwer 2006 Half-Year ResultsWolters Kluwer 2006 Half-Year Results
Wolters Kluwer 2006 Half-Year Results
Wolters Kluwer
 
Wolters Kluwer 2005 Full-Year Results
Wolters Kluwer 2005 Full-Year ResultsWolters Kluwer 2005 Full-Year Results
Wolters Kluwer 2005 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2007 Full-Year Results
Wolters Kluwer 2007 Full-Year ResultsWolters Kluwer 2007 Full-Year Results
Wolters Kluwer 2007 Full-Year Results
Wolters Kluwer
 
Wolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year ResultsWolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year Results
Wolters Kluwer
 

Plus de Wolters Kluwer (20)

Wolters Kluwer 2013 Half-Year Results Presentation
Wolters Kluwer 2013 Half-Year Results PresentationWolters Kluwer 2013 Half-Year Results Presentation
Wolters Kluwer 2013 Half-Year Results Presentation
 
Knowledge Management: Cornerstone of the Digital World
Knowledge Management: Cornerstone of the Digital WorldKnowledge Management: Cornerstone of the Digital World
Knowledge Management: Cornerstone of the Digital World
 
2012 Full-Year Results presentation
2012 Full-Year Results presentation2012 Full-Year Results presentation
2012 Full-Year Results presentation
 
2012 Investor Event: Wolters Kluwer Financial & Compliance Services
2012 Investor Event: Wolters Kluwer Financial & Compliance Services2012 Investor Event: Wolters Kluwer Financial & Compliance Services
2012 Investor Event: Wolters Kluwer Financial & Compliance Services
 
The Next Frontier in Health Information Delivery
The Next Frontier in Health Information DeliveryThe Next Frontier in Health Information Delivery
The Next Frontier in Health Information Delivery
 
GAPP Visit to Wolters Kluwer Headquarters
GAPP Visit to Wolters Kluwer HeadquartersGAPP Visit to Wolters Kluwer Headquarters
GAPP Visit to Wolters Kluwer Headquarters
 
The Perfect Storm: The Rise of Evidence-Based Approach to Risk Management
The Perfect Storm: The Rise of Evidence-Based Approach to Risk ManagementThe Perfect Storm: The Rise of Evidence-Based Approach to Risk Management
The Perfect Storm: The Rise of Evidence-Based Approach to Risk Management
 
Wolters Kluwer 2012 Half-Year Investor Presentation
Wolters Kluwer 2012 Half-Year Investor PresentationWolters Kluwer 2012 Half-Year Investor Presentation
Wolters Kluwer 2012 Half-Year Investor Presentation
 
Wolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year ResultsWolters Kluwer 2007 Half-Year Results
Wolters Kluwer 2007 Half-Year Results
 
Wolters Kluwer 2006 Full-Year Results
Wolters Kluwer 2006 Full-Year ResultsWolters Kluwer 2006 Full-Year Results
Wolters Kluwer 2006 Full-Year Results
 
Wolters Kluwer 2010 Full-Year Results
Wolters Kluwer 2010 Full-Year ResultsWolters Kluwer 2010 Full-Year Results
Wolters Kluwer 2010 Full-Year Results
 
Wolters Kluwer 2010 Half-Year Results
Wolters Kluwer 2010 Half-Year ResultsWolters Kluwer 2010 Half-Year Results
Wolters Kluwer 2010 Half-Year Results
 
Wolters Kluwer 2009 Full-Year Results
Wolters Kluwer 2009 Full-Year ResultsWolters Kluwer 2009 Full-Year Results
Wolters Kluwer 2009 Full-Year Results
 
Wolters Kluwer 2009 Half-Year Results
Wolters Kluwer 2009 Half-Year ResultsWolters Kluwer 2009 Half-Year Results
Wolters Kluwer 2009 Half-Year Results
 
Wolters Kluwer 2008 Full-Year Results
Wolters Kluwer 2008 Full-Year ResultsWolters Kluwer 2008 Full-Year Results
Wolters Kluwer 2008 Full-Year Results
 
Wolters Kluwer 2008 Half-Year Results
Wolters Kluwer 2008 Half-Year ResultsWolters Kluwer 2008 Half-Year Results
Wolters Kluwer 2008 Half-Year Results
 
Wolters Kluwer 2006 Half-Year Results
Wolters Kluwer 2006 Half-Year ResultsWolters Kluwer 2006 Half-Year Results
Wolters Kluwer 2006 Half-Year Results
 
Wolters Kluwer 2005 Full-Year Results
Wolters Kluwer 2005 Full-Year ResultsWolters Kluwer 2005 Full-Year Results
Wolters Kluwer 2005 Full-Year Results
 
Wolters Kluwer 2007 Full-Year Results
Wolters Kluwer 2007 Full-Year ResultsWolters Kluwer 2007 Full-Year Results
Wolters Kluwer 2007 Full-Year Results
 
Wolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year ResultsWolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year Results
 

Dernier

Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
Terna SpA
 
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
dyuozua
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
sovco
 
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
xzxvi5zp
 
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
dyuozua
 
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
dyuozua
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
Probe Gold
 
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
dyuozua
 
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
dyuozua
 

Dernier (20)

Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
 
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
一比一原版(RUG毕业证书)格罗宁根大学毕业证成绩单原件一模一样
 
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
一比一原版(Massey毕业证书)梅西大学毕业证成绩单原件一模一样
 
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
一比一原版(Mac毕业证书)麦克马斯特大学毕业证成绩单原件一模一样
 
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
 
Osisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 ResultsOsisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 Results
 
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
一比一原版(UCD毕业证书)都柏林大学毕业证成绩单原件一模一样
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
 
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
 
Teekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings Presentation
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
一比一原版(UNITEC毕业证书)UNITEC理工学院毕业证成绩单原件一模一样
 
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
一比一原版(Waikato毕业证书)怀卡托大学毕业证成绩单原件一模一样
 
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
一比一原版(UC毕业证书)坎特伯雷大学毕业证成绩单原件一模一样
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 Presentation
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
 
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
一比一原版(AUT毕业证书)奥克兰理工大学毕业证成绩单原件一模一样
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
一比一原版(Galway毕业证书)爱尔兰高威大学毕业证成绩单原件一模一样
 

2015 Full-Year Results

  • 1. Wolters Kluwer 2015 Full-Year Results Nancy McKinstry – CEO Kevin Entricken – CFO February 24, 2016
  • 2. 2015 Full-Year Results 2 This presentation contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions, conditions in the markets in which Wolters Kluwer is engaged, behavior of customers, suppliers and competitors, technological developments, the implementation and execution of new ICT systems or outsourcing, legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions and divestments. In addition, financial risks, such as currency movements, interest rate fluctuations, liquidity and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Growth rates are cited in constant currencies unless otherwise noted. Forward-looking Statements
  • 3. 2015 Full-Year Results 3  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix Agenda
  • 4. 2015 Full-Year Results 4  Organic growth improved to +3% – Digital & services revenues grew +5% organically (83% of total revenues)  Met or exceeded guidance – Adjusted operating profit margin increased in line with guidance – Adjusted free cash flow up +7% in constant currencies, better than expected – ROIC improved – Diluted adjusted EPS up +5% in constant currencies, in line with guidance  Outlook 2016 – Increasing returns to shareholders (dividend and share buyback) – Our plan for 2016-2018 builds on the strategic direction we have been following – Guidance 2016: mid-single-digit growth in diluted adjusted EPS in constant currencies, supported by organic growth and margin improvement Introduction Strategy is delivering improved performance
  • 5. 2015 Full-Year Results 5 Strategic progress Key achievements 2015 ▪ Delivered 7% organic growth in leading, growth positions ▪ Acquired Learner’s Digest International in Health and smaller bolt-on assets in Tax & Accounting ▪ Divested Russia and several non-core assets ▪ Sustained investment in new and enhanced products at 8-10% of revenues ▪ Launched UpToDate China, Cheetah, and several other innovations across all divisions ▪ Formed new division: Governance, Risk & Compliance ▪ Executed on operational excellence programs ▪ Merged medical research and books businesses ▪ Leveraged technology platforms and components across borders Expand our leading, high growth positions Deliver solutions and insights Drive efficiencies
  • 6. 2015 Full-Year Results 6  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix Agenda
  • 7. 2015 Full-Year Results 7 Full-year 2015 results Organic growth accelerated, operating margin and ROIC improved (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Revenues 4,208 3,660 +15% +3% +3% Adjusted operating profit 902 768 +17% +2% +3% Adjusted operating profit margin 21.4% 21.0% Diluted adjusted EPS €1.96 €1.57 +25% +5% Adjusted free cash flow 647 516 +26% +7% Net-debt-to-EBITDA ratio 1.7x 2.1x Return on Invested Capital 9.3% 8.5% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
  • 8. 2015 Full-Year Results 8 (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Health 1,022 816 +25% +6% +5% Tax & Accounting 1,132 989 +14% +4% +3% Governance, Risk & Compliance 1,065 854 +25% +7% +5% Legal & Regulatory 989 1,001 -1% -5% -2% Total revenues 4,208 3,660 +15% +3% +3% FY 2015 Revenues Revenues – new divisions Organic growth in Health, Tax & Accounting, and Governance, Risk & Compliance more than offset decline in Legal & Regulatory Health 24% Tax & Accounting 27% Governance Risk & Compliance 25% Legal & Regulatory 24% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
  • 9. 2015 Full-Year Results 9 (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Legal & Regulatory 1,626 1,497 +9% 0% 0% Tax & Accounting 1,078 946 +14% +3% +3% Health 1,022 816 +25% +6% +5% Financial & Compliance Services 482 401 +20% +6% +6% Total revenues 4,208 3,660 +15% +3% +3% FY 2015 Revenues Revenues – previous divisions Tax & Accounting, Health and Financial & Compliance Services drive growth Legal & Regulatory 39% Tax & Accounting 26% Health 24% F&CS 11% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
  • 10. 2015 Full-Year Results 10 Revenues by region Organic growth continues to be driven by North America and Asia Pacific & ROW North America 59% Europe 33% AsiaPac & ROW 8% FY 2015 Revenues ∆ OG: +5% (+3%) (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG North America 2,509 1,999 +26% +5% +5% Europe 1,371 1,373 0% -1% -1% AsiaPac & ROW 328 288 +14% +4% +4% Total revenues 4,208 3,660 +15% +3% +3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. Legend: ∆ OG - % Organic Growth FY 2015 (FY 2014) ∆ OG: -1% (0%) ∆ OG: +4% (+7%)
  • 11. 2015 Full-Year Results 11 Digital 70% Services 13% Print 17% Revenues by media format Digital revenues sustained 6% organic growth (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Digital 2,962 2,472 +20% +7% +6% Services 523 453 +16% 0% +3% Print 723 735 -1% -9% -7% Total revenues 4,208 3,660 +15% +3% +3% FY 2015 Revenues ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. ∆ OG: +6% (+6%) ∆ OG: -7% (-9%) ∆ OG: +3% (0%) Legend: ∆ OG - % Organic Growth FY 2015 (FY 2014)
  • 12. 2015 Full-Year Results 12 (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Margin FY 2015 Margin FY 2014 Health 247 197 +25% +5% +4% 24.1% 24.1% Tax & Accounting 311 261 +19% +7% +8% 27.5% 26.4% Governance, Risk & Compliance 298 232 +29% +9% +8% 28.0% 27.1% Legal & Regulatory 96 127 -24% -28% -23% 9.7% 12.7% Corporate (50) (49) +4% 0% 0% Adjusted operating profit 902 768 +17% +2% +3% 21.4% 21.0% FY 2015 Adjusted Operating Profit Adjusted operating profit – new divisions Margin increases in Tax & Accounting and Governance, Risk & Compliance more than offset expected decline in Legal & Regulatory margin Legal & Regulatory 10% Tax & Accounting 33% Health 26% Governance Risk & Compliance 31% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. * Excluding corporate
  • 13. 2015 Full-Year Results 13 (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Margin FY 2015 Margin FY 2014 Legal & Regulatory 320 305 +5% -8% -7% 19.7% 20.3% Tax & Accounting 295 250 +18% +6% +7% 27.4% 26.4% Health 247 197 +25% +5% +4% 24.1% 24.1% Financial & Compliance Services 90 65 +37% +21% +21% 18.6% 16.3% Corporate (50) (49) +4% 0% 0% Adjusted operating profit 902 768 +17% +2% +3% 21.4% 21.0% FY 2015 Adjusted Operating Profit Adjusted operating profit – previous divisions Financial & Compliance Services was a key contributor to the margin increase Legal & Regulatory 34% Tax & Accounting 31% Health 26% F&CS 9% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. * Excluding corporate
  • 14. 2015 Full-Year Results 14 Adjusted net profit and EPS Diluted adjusted EPS up +5% in constant currencies (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC Revenues 4,208 3,660 +15% +3% Adjusted operating profit 902 768 +17% +2% Adjusted operating profit margin 21.4% 21.0% Adjusted net financing costs (119) (113) Equity-accounted investees, net of tax 0 (1) Adjusted profit before tax 783 654 +20% +3% Tax on adjusted profit (199) (182) Effective benchmark tax rate 25.5% 27.6% Non-controlling interests (1) (2) Adjusted net profit 583 470 +24% +4% Diluted weighted average shares (million) 297.4 299.9 Diluted adjusted EPS €1.96 €1.57 +25% +5% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33).
  • 15. 2015 Full-Year Results 15 IFRS profit and diluted EPS Reported EPS declines 10%, reflecting one-off factors related to tax (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ Adjusted operating profit 902 768 +17% Amortization of acquired intangibles (214) (192) Results on divestments of operations (14) 10 Acquisition integration costs and other non-benchmark items (7) (17) Operating profit 667 569 +17% Financing results1) (125) (56) Share of profit of equity-accounted investees, net of tax 0 (1) Profit before tax 542 512 +6% Income tax expense (119) (38) Effective tax rate2) 21.9% 7.4% Profit for the period 423 474 -11% Non-controlling interests 0 (1) Profit for the period to the owners of the Company 423 473 -11% Diluted EPS €1.42 €1.58 -10% ∆: % Change 1) Includes the financing component of employee benefits (€5 million in 2015 and 2014). In 2014, includes €76 million revaluation gain on Datacert. 2) 2014 effective tax rate reflects the non-taxable revaluation gain on Datacert, a positive tax impact relating to previously divested assets, and a tax charge on internal asset transfers.
  • 16. 2015 Full-Year Results 16 Adjusted free cash flow Cash conversion of 100%, better than expected (€ million, unless otherwise stated) FY 2015 FY 2014 ∆ ∆ CC Adjusted operating profit 902 768 +17% +2% Depreciation and amortization of other intangibles 171 140 Adjusted EBITDA 1,073 908 +18% +3% Capital expenditure (188) (148) Autonomous movements in working capital 18 4 Adjusted operating cash flow 903 764 +18% +4% Cash conversion ratio 100% 100% Paid financing costs (101) (135) Paid corporate income tax1) (141) (101) Net change in restructuring provision2) (6) (9) Other3) (8) (3) Adjusted free cash flow 647 516 +26% +7% Springboard, net of tax2) - (4) Adjusted free cash flow, incl. Springboard4) 647 512 +26% +7% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33). 1) 2014 adjusted for tax on appropriation of Springboard provisions. 2) In 2015, the appropriation of Springboard provisions (€3 million) was included in adjusted free cash flow. In 2014, the appropriation of Springboard provisions was treated as a non-benchmark item. 3) ‘Other’ includes share-based payments, dividends received, an adjustment to remove a €22 million income tax benefit relating to previously divested assets (2014: €18 million) and a €5 million transactional tax payment relating to the 2014 internal asset transfers. 4) Adjusted free cash flow excludes additions to provisions for acquisition integration.
  • 17. 2015 Full-Year Results 17 Movement in net debt Leverage ratio improved to 1.7x, despite over 55% of free cash flow returned to shareholders (€ million, unless otherwise stated) FY 2015 FY 2014 Net debt at January 1 (1,897) (1,988) Adjusted free cash flow, incl. Springboard 647 512 Dividends paid (263) (209) Acquisition spending, net of cash acquired, including costs (183) (189) Divestiture cash proceeds, including costs, net of cash disposed 22 27 Share repurchases (140) (25) Other1) 26 (25) Movement in net debt 109 91 Net debt at December 31 (1,788) (1,897) Net-debt-to-EBITDA ratio 1.7x 2.1x 1) In 2015, ‘Other’ includes a €22 million income tax benefit on previously divested assets, a €5 million one-off tax payment on internal asset transfers, as well as adjustments for FX differences in cash and cash equivalents, changes in the fair value of derivatives, and other items.
  • 18. 2015 Full-Year Results 18 Leverage Net-debt-to-EBITDA improved to 1.7x, better than target level 2.7x 3.1x 2.4x 2.2x 2.1x 1.7x 2010 2011 2012 2013 2014 2015 Net-Debt-to-EBITDA (Ratio) Target: 2.5x
  • 19. 2015 Full-Year Results 19 Dividend Proposing full-year total dividend of €0.75 per share, up +6% Dividend per Share (€)1) 1) Dividend declared for the year indicated  2015: introduced semi-annual dividend frequency. Interim dividend of €0.18 paid in October 2015  Proposing final dividend of €0.57, subject to AGM approval, to be paid in May 2016  2015: 10th consecutive year of increase in dividend per share  Progressive dividend policy: committed to increase the total dividend per share each year Proposed final dividend €0.57 0.55 0.58 0.64 0.65 0.66 0.67 0.68 0.69 0.70 0.71 0.75 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Interim dividend €0.18
  • 20. 2015 Full-Year Results 20 Share buybacks Completed €140 million share buyback in 2015. Announcing up to €600 million buyback over the next three years (2016-2018)  Committed to anti-dilution policy to offset dilution caused by performance share issuance  Announcing intention to buy back up to €600 million in shares over three years (2016-2018), including anti- dilution buybacks  Ample headroom to continue investing in the business, including acquisitions 100 135 20 25 140 2011 2012 2013 2014 2015 2016 2017 2018 Share Buybacks (€ million) Share Buyback Program 2016-2018: up to €600 million
  • 21. 2015 Full-Year Results 21  Organic growth accelerated to +3%  Adjusted operating margin 21.4%, increased by 40 basis points  Diluted adjusted EPS €1.96, up +5% in constant currencies  Adjusted free cash flow of €647 million, up +7% in constant currencies  Net-debt-to-EBITDA ratio improved to 1.7x  Proposing full-year total dividend of €0.75 per share  Announcing up to €600 million share buyback over three years (2016-2018), including anti-dilution buybacks Summary
  • 22. 2015 Full-Year Results 22  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix Agenda
  • 23. 2015 Full-Year Results 23 Health Sustained +5% organic growth; margin reflects increased investment and restructuring Clinical Solutions 47% Health Learning, Research & Practice 53% North America 73% Europe 10% AsiaPac & ROW 17% € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,022 816 +25% +6% +5% Adjusted operating profit 247 197 +25% +5% +4% Margin 24.1% 24.1% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. Clinical Solutions  Organic growth +10%, driven by double- digit growth of UpToDate  Drug information sustained robust growth  Medical documentation and informatics were subdued, facing tough comparable and longer sales lead times  Increased investment in sales and marketing and product development Health Learning, Research & Practice  Organic growth improved to +1%  Digital growth outweighed print decline  Increased restructuring to merge former journal and book units  Acquisition of digital leader in continuing medical education, Learner’s Digest Int’l Revenues by Geographic MarketRevenues by Segments
  • 24. 2015 Full-Year Results 24 Tax & Accounting software 71% Other digital 16% Services 6% Print 7% Tax & Accounting Organic growth +3% supported by software +6%; margins improved € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,132 989 +14% +4% +3% Adjusted operating profit 311 261 +19% +7% +8% Margin 27.5% 26.4% North America 59% Europe 30% AsiaPac & ROW 11% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. Revenues by Media Format Revenues by Geographic Market North America  Good organic growth driven by software and other digital products  Cloud-based suite, CCH Axcess, continues to migrate and attract new users  Print, bank products, and training remain weak Europe  Good organic growth in most countries  On-premise software performed well  Investing in cloud-based and collaborative solutions Asia Pacific & ROW  Growth abates to low single-digit rate  Software growth partly offset by print Audit (TeamMate)  Double-digit organic growth driven by new software sales
  • 25. 2015 Full-Year Results 25 North America 84% Europe 13% AsiaPac & ROW 3% Governance, Risk & Compliance Organic growth +5%, buoyed by non-recurring revenues; margins improved € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,065 854 +25% +7% +5% Adjusted operating profit 298 232 +29% +9% +8% Margin 28.0% 27.1% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. Corporate Legal Services 60% Finance, Risk & Complianc 21% Transport Svcs 4% Originations 15% Corporate Legal Services  Organic growth +6%, including +2% in 4Q  CLS transactional revenues +8%  All areas performed well Originations  High single-digit organic growth driven by TILA-RESPA regulation  FS transactional declined against tough comparable Finance, Risk & Compliance  Organic growth +6%, despite challenging comparable  Higher non-recurring license and implementation fees  Steady growth in recurring revenues Transport Services (Europe)  Revenues decline moderated; margins improved Revenues by Segments Revenues by Geographic Market
  • 26. 2015 Full-Year Results 26 Digital 48% Services 11% Print 41% North America 20% Europe 79% AsiaPac & ROW 1% € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 989 1,001 -1% -5% -2% Adjusted operating profit 96 127 -24% -28% -23% Margin 9.7% 12.7% Legal & Regulatory Organic decline as print still outweighs digital growth; margins impacted by planned increase in restructuring Revenues by Media Format ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth. Legal & Regulatory  Organic growth -2%, improving modestly (2014: -3%)  Digital revenues up +1% organically  Investing in legal and regulatory compliance software  Acquisition of Effacts, legal management software for corporate counsel, supports strategy  Print formats continued to decline, although books improved due to publishing schedules and front list  Margin contracted, as expected, due to increased costs, including restructuring  Divested Russia (55% interest) and non- core assets in the U.K., U.S. and Germany Revenues by Geographic Market
  • 27. 2015 Full-Year Results 27 61% 70% 13% 13% 26% 17% 2012 2015 Digital Services Print 74% 76% 17% 17% 9% 7% 2012 2015 Recurring Non-recurring Print Books Revenues by Media Format Strategy 2013-2015 Our strategy of the past few years has driven continued portfolio transformation Note: 2012 excludes discontinued operations. Revenue breakdown by media format and type reflects updated product classifications introduced in 2014. 54% 59% 6% 8% 40% 33% 2012 2015 Europe Asia Pacific & RoW North America Revenues by Type Revenues by Geographic Market & transactional
  • 28. 2015 Full-Year Results 28 Strategy 2013-2015 Leading, high growth units, now 51% of total revenues, grew +7% organically 39% 71% 47% 58% +6% +7% +10% +5% 1) Previous divisional structure. % of divisional revenues 2015 Organic Growth Leading High Growth Units 2015 28% 56% 38% 49% 2012 Corporate Legal Services Finance, Risk & Compliance; Audit Clinical Solutions Tax & Accounting Software 40% of total revenues 51% of total revenues Legal & Regulatory F&CS Health Tax & Accounting Divisions:1) Total Leading High Growth +7%
  • 29. 2015 Full-Year Results 29 Organic growth and margin Organic growth accelerated and margin improved -3% 0% 1% 1% 1% 2% 3% 2% 4% 4% 5% 5% 6% 6% 2009 2010 2011 2012 2013 2014 2015 Note: Organic growth and Adjusted operating profit margin as reported. 2011-2013 reflects continuing operations. All restructuring costs included in adjusted operating profit margin since 2012. 2012 restated for IAS 19R (Employee benefits) and early adoption of IFRS 11 (Joint arrangements). Digital revenue growth as of 2014 reflects updated product classifications. Digital revenues Total Wolters Kluwer Organic Growth (%) 19.9% 20.4% 21.7% 21.5% 21.5% 21.0% 21.4% 2009 2010 2011 2012 2013 2014 2015 Adjusted Operating Profit Margin (%)
  • 30. 2015 Full-Year Results 30 Continued pressure on professionals to improve outcomes and productivity Increasing volume and complexity of global regulation, risk and compliance High growth of professionals in developing economies Increasing disruption from cloud, mobile, social media, Big Data & Artificial Intelligence 5 Market trends Changing customer needs are creating opportunities and challenges Changing client needs: millennials work differently and seek rich digital experience 421 3
  • 31. 2015 Full-Year Results 31 Strategic priorities 2016-2018 Our plan for 2016-2018 builds on the strategic direction of the past three years ▪ Allocate majority of capital to leading, growing businesses ▪ Extend into adjacent market segments and new geographies ▪ Broaden our global sales and marketing coverage ▪ Deliver expert solutions providing improved outcomes and productivity ▪ Accelerate development of global platforms and cloud-based solutions ▪ Expand new media marketing channels ▪ Continue investing 8-10% of revenues into new and enhanced products ▪ Continue driving scale economies while improving quality and agility ▪ Leverage our technology investments through increased standardization of processes and technology planning ▪ Foster employee engagement Expand Market Coverage Deliver Expert Solutions Drive Efficiencies & Engagement
  • 32. 2015 Full-Year Results 32 Product innovation Continued investment in Expert Solutions and other digital innovation Cheetah New intuitive legal research platform UpToDate Clinical decision support resource for healthcare practitioners 2015  Double-digit organic growth; reached 1.1 million users globally  Unveiled 23rd specialty - Sports Medicine  Commercial launch in China – 4,800 topics translated by year-end 2015 – Signed first customers 2015  Greatly enhanced usability, speed and accuracy of research results  Offers Federal, State, and International Tax Law; Intellectual Property Law to be released in 1H 2016  Upgrading existing users and attracting new customers
  • 33. 2015 Full-Year Results 33  Introduction  Financial Review  Strategic and Operating Review  Outlook 2016  Appendix Agenda
  • 34. 2015 Full-Year Results 34 Divisional outlook 2016 Legal & Regulatory  Expect positive but slower organic growth, due to challenging comparables for transactional and non-recurring revenues, particularly in the first half  Margins expected to improve slightly Tax & Accounting  Expect underlying revenue growth to improve slightly, driven by continued mix shift towards software solutions  Margin expected to ease in the first half, but to be maintained for the full year Health  Another year of good organic growth, supported by robust growth in Clinical Solutions and gradually improving trend in Health Learning, Research & Practice  Expect slight margin improvement as we continue to invest to drive growth Governance, Risk & Compliance  Expect organic revenue decline similar to 2015, with print trends continuing to outweigh digital growth. First half growth to benefit from timing and one-offs  Margin expected to improve due to lower restructuring costs. Efficiency savings are expected to fund wage inflation and increased investment
  • 35. 2015 Full-Year Results 35 Guidance 2016 Performance indicators FY 2016 Guidance Adjusted operating profit margin 21.5%–22.0% Adjusted free cash flow €600-€625 million Return on invested capital > 9% Diluted adjusted EPS Mid-single-digit growth Guidance for adjusted free cash flow and diluted adjusted EPS is in constant currencies (EUR/USD 1.11). Guidance for EPS growth assumes the announced share repurchases are equally spread over 2016-2018. Adjusted operating profit margin and ROIC are in reported currency. Additional information: Expect adjusted net financing costs of approximately €105 million, excluding the impact of exchange rate movements. Expect the benchmark effective tax rate to return to the range of 27% - 28%. Expect a cash conversion ratio of approximately 95%, with capital expenditure rising to around 5% of total revenue.
  • 36. Q&A
  • 38. 2015 Full-Year Results 38 (€ million, unless otherwise stated) Dec. 31, 2015 Dec. 31, 2014 Goodwill and intangible assets 5,550 5,172 Equity-accounted investees and financial assets 30 32 Other non-current assets 208 216 Non-current assets 5,788 5,420 Cash and cash equivalents 812 535 Other current assets 1,499 1,381 Deferred income (1,522) (1,344) Short-term borrowings and bank overdrafts (286) (125) Other current liabilities (962) (924) Working capital (459) (477) Capital employed 5,329 4,943 Total equity 2,477 2,121 Long-term debt 2,306 2,304 Other non-current liabilities 546 518 Total financing 5,329 4,943 Closing rate EUR/USD 1.09 1.21 Balance Sheet
  • 39. 2015 Full-Year Results 39 Reconciliation: Adjusted net financing costs to financing results (€ million) FY 2015 FY 2014 Adjusted net financing costs (119) (113) Loss on investment available-for-sale - (14) Employee benefits financing component (5) (5) Divestment related results on equity-accounted investees (1) 76 Financing results (125) (56)
  • 40. 2015 Full-Year Results 40 Recurring 76% Print books 7% Other non- recurring 17% Revenues by type (€ million) FY 2015 FY 2014 ∆ ∆ CC ∆ OG Digital and services subscriptions 2,561 2,155 +19% +6% +5% Print subscriptions 314 341 -8% -12% -9% Other recurring 326 281 +16% +1% +0% Recurring revenues 3,201 2,777 +15% +3% +3% Print books 299 289 +4% -6% -5% CLS transactional 278 215 +29% +8% +8% FS transactional 42 37 +14% -5% -5% Other non-recurring 388 342 +13% +3% +3% Total revenues 4,208 3,660 +15% +3% +3% FY 2015 Revenues ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth.
  • 41. 2015 Full-Year Results 41 Recurring 82% Print books 12% Other non- recurring 6% Digital 78% Services 1% Print 21% Revenues by media format and type Tax & Accounting software 71% Digital: other 16% Services 6% Print 7% Tax & Accounting Recurring 89% Print books 3% Other non- recurring 8% Health Governance, Risk & Compliance Legal & Regulatory Digital 66% Services 32% Print 2% Recurring 59% CLS transactional 26% FS transactional 4% Other non- recurring 11% Digital 48% Services 11% Print 41% Recurring 74% Print books 14% Other non- recurring 12% FY 2015 Revenues
  • 42. 2015 Full-Year Results 42 Debt maturity profile 294 752 12 248 5 697 196 396 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 >2025 Debt Maturity Profile (€ million) year-end Cash & cash equivalents 812 Debt due in 2016 includes €285 million of bank overdrafts used for cash management purposes. Total cash and cash equivalents, less bank overdrafts used for cash management purposes, were €527 million.
  • 43. 2015 Full-Year Results 43 Tax & Accounting software 71% Digital: other 16% Services 6% Print 7% Former Tax & Accounting North America 60% Europe 31% AsiaPac & ROW 9% Revenues by Media Format Revenues by Geographic Market € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,078 946 +14% +3% +3% Adjusted operating profit 295 250 +18% +6% +7% Margin 27.4% 26.4% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth
  • 44. 2015 Full-Year Results 44 Former Financial & Compliance Services Originations 34% Finance, Risk & Compliance 47% Audit 11% Transport Svcs 8% North America 65% Europe 26% AsiaPac & ROW 9% F&CS Segments € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 482 401 +20% +6% +6% Adjusted operating profit 90 65 +37% +21% +21% Margin 18.6% 16.3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth Revenues by Geographic Market
  • 45. 2015 Full-Year Results 45 Corporate Legal Services 39% Legal & Regulatory Solutions 61% North America 50% Europe 50% L&R Segments € million FY 2015 FY 2014 Δ Δ CC Δ OG Revenues 1,626 1,497 +9% 0% 0% Adjusted operating profit 320 305 +5% -8% -7% Margin 19.7% 20.3% ∆: % Change; ∆ CC: % Change constant currencies (EUR/USD 1.33); ∆ OG: % Organic growth Former Legal & Regulatory Revenues by Geographic Market